text.skipToContent text.skipToNavigation

 IMPORTANT UPDATE:  Some items may be delayed in shipping or out of stock due to extremely high demand.

Corning® Supersomes™ Human CYP2C9*1 (Arg144) + Oxidoreductase + b5, 0.5 nmol

Product Number 456258

Recombinant enzyme prepared from insect cells infected with baculovirus containing desired cDNAs

CYP2C9 is responsible for metabolizing 10-20% of commonly prescribed medications. Drugs metabolized by CYP2C9 include diclofenac, ibuprofen, naproxin, celecoxib (COX 2 inhibitor, Celobrex), losartan, S-warfarin (Coumadin, racemic mixture of the R and S enantiomers), tamoxifen, fluvastatin, fluoxetine, and tolbutamide. CYP2C9 also metabolizes benzo(a)pyrene, a promutagen or procarcinogen. Diclofenac 4’-hydroxylation is a recommended CYP2C9 probe substrate.

Among the three common alleles: CYP2C9*1 (Arg144, Ile359), CYP2C9*2 (Cys144) and CYP2C9*3 (Leu359), CYP2C9*1 is the most common allelic variant in human populations studied to date and is considered the wild-type allele. All 3 allelic variants have similar rates of catalysis for diclofenac 4’-hydroxylation, while CYP2C9*2 and CYP2C9*3 alleles exhibit reduced rates of turnover relative to CYP2C9*1 for selected substrates, such as S-warfarin, leading to reduced intrinsic clearance.

  • Contains Human Oxidoreductase and cytochrome b₅
  • Available size: 0.5 nmole P450 in 0.5 mL
  • Protein concentration: Available in batch data sheet. Contact Corning Scientific support to obtain the information.

This product is non-returnable. If you have any questions, please contact us immediately.

$157.83 per each

In Stock

Product Number   456258
Qty./Pk   1 / Pk  
Qty./Cs   1 / Ea  
Brand   Corning®  
Size   0.5 nmol  
Species   Human  
Enzyme Type   P450  
Protein Concentration   Lot-dependent  
Storage   -80°C  
Cellular Location   Microsome  
Specifications Documents